Preliminary results of a phase II trial on targeted therapy with cetuximab in EGFR-expressing adenoid cystic carcinoma of the oral cavity

被引：0
|
作者：
Hitre, Erika [1 ]
Boer, Andras [1 ]
Remenar, Eva [1 ]
Takacsi-Nagy, Zoltan [1 ]
Godeny, Maria [1 ]
Kasler, Miklos [1 ]
Lang, Istvan [1 ]
机构：
[1] Natl Inst Oncol, Budapest, Hungary
来源：
ANNALS OF ONCOLOGY | 2006年 / 17卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：188 / 188
页数：1
相关论文
共 50 条
  • [21] Phase II study of lapatinib in recurrent or metastatic epidermal growth factor receptor and/or erbB2 expressing adenoid cystic carcinoma and non-adenoid cystic carcinoma malignant tumors of the salivary glands
    Agulnik, Mark
    Cohen, Ezra W. E.
    Cohen, Roger B.
    Chen, Eric X.
    Vokes, Everett E.
    Hotte, Sebastien J.
    Winquist, Eric
    Laurie, Scott
    Hayes, D. Neil
    Dancey, Janet E.
    Brown, Shirley
    Pond, Gregory R.
    Lorimer, Ian
    Daneshmand, Manijeh
    Ho, James
    Tsao, Ming-Sound
    Siu, Lillian L.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (25) : 3978 - 3984
  • [22] Oral bropirimine immunotherapy of carcinoma in situ of the bladder: Results of a Phase II trial
    Sarosdy, MF
    Lowe, BA
    Schellhammer, PF
    Lamm, DL
    Graham, SD
    Grossman, HB
    See, WA
    Peabody, JO
    Moon, TD
    Flanigan, RC
    Crawford, ED
    Morganroth, J
    UROLOGY, 1996, 48 (01) : 21 - 27
  • [23] Anti-EGFR antibody Cetuximab in refractory or relapsed multiple myeloma: Final results of a phase II clinical trial
    von Tresckow, B.
    Boell, B.
    Eichenauer, D. A.
    Peine, D.
    Knop, S.
    Goebeler, M.
    Chemnitz, J.
    Hallek, M.
    Engert, A.
    Huebel, K.
    ONKOLOGIE, 2011, 34 : 242 - 242
  • [24] Phase II trial of apatinib in patients with recurrent and/or metastatic adenoid cystic carcinoma of the head and neck: Updated analysis.
    Zhu, Guopei
    Zhang, Lin
    Li, Rongrong
    Dou, Shengjin
    Yang, Wenjun
    Zhang, Chenping
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [25] Targeted stem cells expressing TRAIL as a therapy for lung Cancer TACTICAL: a phase I/II trial
    Sage, E.
    Davies, A.
    Kolluri, K.
    Patrick, S.
    Weil, B.
    Rego, R. Vitorino Tendeiro Pereira
    Edwards, A.
    Bain, O.
    Santilli, G.
    Thakrar, R.
    Champion, K.
    Day, A.
    Popova, B.
    Fullen, D.
    Thrasher, A.
    Kalber, T.
    Forster, M.
    Lythgoe, M.
    Lowdell, M.
    Janes, S. M.
    LUNG CANCER, 2018, 115 : S87 - S87
  • [26] TARGETED STEM CELLS EXPRESSING TRAIL AS A THERAPY FOR LUNG CANCER TACTICAL: A PHASE I/II TRIAL
    Davies, A. V.
    Sage, E. K.
    Kolluri, K.
    Weil, B.
    Rego, R. Vitorino Tendeiro Pereira
    Edwards, A.
    Bain, O.
    Santilli, G.
    Fullen, D.
    Champion, K.
    Day, A.
    Wheeler, G.
    Popova, B.
    Thrasher, A.
    Forster, M.
    Lowdell, M. W.
    Janes, S. M.
    THORAX, 2017, 72 : A222 - A223
  • [27] Results of a phase II trial of combination therapy with oral capecitabine and weekly paclitaxel for metastatic breast cancer: preliminary results in taxane pretreated women
    Blum, JL
    Dees, EC
    Asmar, L
    Vukelja, S
    McMahon, R
    Amare, M
    Gill, D
    Ilegbodu, D
    Boehm, KA
    O'Shaughnessy, J
    BREAST CANCER RESEARCH AND TREATMENT, 2005, 94 : S280 - S280
  • [28] LOCAL CONTROL FOLLOWING COMBINATION HYPOFRACTIONATED RADIOTHERAPY AND PEMBROLIZUMAB IN A PHASE II TRIAL OF RECURRENT OR METASTATIC ADENOID CYSTIC CARCINOMA PATIENTS
    Bang, Andrew
    Mahmood, Umair
    Chen, Yu-Hui
    Mak, Raymond H.
    Lorch, Jochen H.
    Hanna, Glenn J.
    Sridharan, Vishwajith
    Busse, Paul M.
    Willers, Henning
    Mamon, Harvey J.
    Yoo, Hyung-Jin
    Pai, Sara I.
    Wirth, Lori J.
    Haddad, Robert I.
    Chau, Nicole G.
    Schoenfeld, Jonathan D.
    RADIOTHERAPY AND ONCOLOGY, 2019, 139 : S26 - S27
  • [29] A Phase II Clinical Trial of the Anti-EGFR Antibody Cetuximab in Patients with Refractory or Relapsed Multiple Myeloma: Final Results
    von Tresckow, Bastian
    Boell, Boris
    Eichenauer, Dennis A.
    Peine, Denissa
    Knop, Stefan
    Goebeler, Mariele
    Chemnitz, Jens M.
    Hallek, Michael
    Engert, Andreas
    Huebel, Kai
    BLOOD, 2011, 118 (21) : 1696 - 1696
  • [30] Local Control following Combination Hypofractionated Radiotherapy and Pembrolizumab in A Phase II Trial of Recurrent or Metastatic Adenoid Cystic Carcinoma Patients
    Bang, A.
    Mahmood, U.
    Chen, Y. H.
    Mak, R. H.
    Lorch, J.
    Hanna, G. J.
    Sridharan, V.
    Busse, P. M.
    Willers, H.
    Mamon, H. J.
    Yoo, H. J.
    Pai, S. I.
    Wirth, L.
    Haddad, R. I.
    Chau, N.
    Schoenfeld, J. D.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2019, 105 (01): : E363 - E363
12345